tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Chugai Highlights Positive Phase 3 Results and FDA Filing for Lilly’s Oral GLP-1 Orforglipron
PremiumCompany AnnouncementsChugai Highlights Positive Phase 3 Results and FDA Filing for Lilly’s Oral GLP-1 Orforglipron
2M ago
Chugai Pharmaceutical to Merge with Renalys Pharma to Boost Kidney Disease Drug Development
Premium
Company Announcements
Chugai Pharmaceutical to Merge with Renalys Pharma to Boost Kidney Disease Drug Development
3M ago
Chugai Pharmaceutical Acquires Renalys Pharma to Expand IgA Nephropathy Treatment
Premium
Company Announcements
Chugai Pharmaceutical Acquires Renalys Pharma to Expand IgA Nephropathy Treatment
4M ago
Eli Lilly’s Orforglipron Shows Superior Results in Diabetes Trial
PremiumCompany AnnouncementsEli Lilly’s Orforglipron Shows Superior Results in Diabetes Trial
5M ago
Chugai Announces Positive Phase 3 Results for Eli Lilly’s Orforglipron
Premium
Company Announcements
Chugai Announces Positive Phase 3 Results for Eli Lilly’s Orforglipron
6M ago
Chugai Highlights Eli Lilly’s Positive Phase 3 Results for Orforglipron
Premium
Company Announcements
Chugai Highlights Eli Lilly’s Positive Phase 3 Results for Orforglipron
7M ago
Chugai Pharmaceutical’s Performance Highlighted in Roche’s Half-Year Results
PremiumCompany AnnouncementsChugai Pharmaceutical’s Performance Highlighted in Roche’s Half-Year Results
7M ago
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
9M ago
Roche’s Chugai Seeks Next Milestone after Finding Success with Eli Lilly’s Obesity Drug
Premium
Market News
Roche’s Chugai Seeks Next Milestone after Finding Success with Eli Lilly’s Obesity Drug
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100